Plantaglucid (Granules) Instructions for Use
ATC Code
A03 (Drugs for the treatment of functional gastrointestinal disorders)
Active Substance
Plantago major (BP British Pharmacopoeia)
Clinical-Pharmacological Group
Herbal preparation that stimulates the secretory and motor functions of the gastrointestinal tract and bronchi
Pharmacotherapeutic Group
Spasmolytic agent of plant origin
Pharmacological Action
A herbal preparation. It has antiseptic, anti-inflammatory, spasmolytic, enveloping, and expectorant effects, promotes tissue regeneration and activates gastric secretion.
The antiseptic effect (against staphylococci, Pseudomonas aeruginosa, hemolytic streptococcus) is due to the presence of phytoncides.
The anti-inflammatory, wound- and ulcer-healing effects are associated with the presence of polysaccharides, pectin and tannins, benzoic and salicylic acids. Polysaccharides activate interferon formation, zinc and flavonoids contribute to the normalization of phagocytosis. The combination of polysaccharides with enzymes and vitamins promotes the acceleration of regeneration. These effects are also closely related to the ability of plantain to increase the resistance of cells and tissues to oxygen deficiency. The pronounced antihypoxic effect is provided by organic (especially citric) and phenolcarboxylic (ferulic, caffeic, coumaric) acids, flavonoids (derivatives of luteolin, quercetin, apigenin), vitamin C, copper and zinc. The hemostatic effect is associated with the presence of vitamin K.
Plantain regulates digestion, increases appetite, reduces the tone of the smooth muscles of the stomach and intestines, and has an anti-inflammatory and regenerating effect in gastritis, gastroduodenitis and other inflammatory diseases of the gastrointestinal tract. Iridoid glycosides, aucubin, catalpol and bitters included in its composition enhance the secretion of gastric juice and increase the acidity of gastric contents.
Due to mucus, enzymes, and phytoncides, plantain also has an expectorant effect, restoring the protective function of the ciliated epithelium of the respiratory tract.
Saponins, hydroxycinnamic acids, flavonoids and pectin substances contribute to lowering blood cholesterol levels.
Indications
Used as part of combination therapy: for the treatment of gastrointestinal diseases – acute and chronic gastritis, gastric and duodenal ulcers with preserved and reduced secretion, enterocolitis, enzymopathies, dysbiosis; for the treatment of infectious and inflammatory diseases of the respiratory organs, including rhinitis, tonsillopharyngitis, bronchitis, pneumonia, whooping cough.
For external use: dermatitis of various etiologies, wounds, cuts, bruises, trophic ulcers, boils, abscesses, burns.
For local use: gynecological diseases, cervical erosion.
ICD codes
| ICD-10 code | Indication |
| A37 | Whooping cough |
| J00 | Acute nasopharyngitis (common cold) |
| J02 | Acute pharyngitis |
| J03 | Acute tonsillitis |
| J04 | Acute laryngitis and tracheitis |
| J15 | Bacterial pneumonia, not elsewhere classified |
| J20 | Acute bronchitis |
| J31 | Chronic rhinitis, nasopharyngitis and pharyngitis |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| J31.2 | Chronic pharyngitis |
| J35.0 | Chronic tonsillitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| K25 | Gastric ulcer |
| K26 | Duodenal ulcer |
| K29 | Gastritis and duodenitis |
| K52.9 | Noninfective gastroenteritis and colitis, unspecified |
| K63.8 | Other specified diseases of intestine |
| L02 | Cutaneous abscess, furuncle and carbuncle |
| L30.9 | Dermatitis, unspecified |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| N76 | Other inflammatory diseases of vagina and vulva |
| N86 | Erosion and ectropion of cervix |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 1B75.0 | Furuncle |
| 1B75.1 | Carbuncle |
| 1B75.2 | Furunculosis |
| 1B75.3 | Pyogenic skin abscess |
| 1C12.Z | Whooping cough, unspecified |
| CA00 | Acute nasopharyngitis |
| CA02.Z | Acute pharyngitis, unspecified |
| CA03.Z | Acute tonsillitis, unspecified |
| CA05 | Acute laryngitis or tracheitis |
| CA09 | Chronic rhinitis, nasopharyngitis or pharyngitis |
| CA09.0 | Chronic rhinitis |
| CA09.2 | Chronic pharyngitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA40.0Z | Bacterial pneumonia, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| DA42.Z | Gastritis, unspecified |
| DA51.Z | Duodenitis, unspecified |
| DA60.Z | Gastric ulcer, unspecified |
| DA63.Z | Duodenal ulcer, unspecified |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DA90.0 | Syndromic diarrhea |
| DA92.1 | Pneumatosis intestinalis of the small intestine |
| DA98.Z | Polyps of small intestine, unspecified |
| DB31.1 | Pneumatosis of the colon |
| DB36.Z | Certain infections of the colon, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
| EA40 | Tropical phagedenic ulcer |
| EA85.2Z | Hand dermatitis, unspecified |
| EA85.3 | Foot dermatitis |
| EA89 | Generalized eczematous dermatitis of unspecified type |
| EA8Z | Dermatitis or eczema, unspecified |
| EF60 | Ischemic ulceration of the skin |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EM0Z | Unspecified skin disorder |
| GA00 | Vulvitis |
| GA02.Z | Unspecified vaginitis |
| GA0Z | Inflammatory diseases of female genital tract, unspecified |
| GA15.1 | Erosion or ectropion of cervix |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.0 | Superficial injury of unspecified body region |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Granules
For the treatment of gastrointestinal diseases, plantain is taken orally as a prepared infusion, 15-50 ml 15-30 minutes before meals. The course of treatment is 1-8 weeks. The juice is taken 1 tablespoon (dissolved in 50 ml of warm water) 15-20 minutes before meals 3-4 times/day for 1 month.
For the treatment of respiratory diseases, plantain is used as an infusion or juice in the same doses but 30 minutes after meals. For colds, juice diluted 5-10 times with warm water can be instilled 2-3 drops into each nostril 3-6 times/day.
For the treatment of dermatological diseases, juice and infusion can be used externally as dressings, lotions or washings, 3-4 times/day, and for burns – regularly, at intervals of 1-1.5 hours.
In gynecological practice, juice is used for douching, sitz baths, instillations, and vaginal tampons.
Adverse Reactions
Rarely: allergic reactions; when taken orally – heartburn.
Contraindications
Hypersensitivity to Plantago major; increased secretion of digestive glands; gastric and duodenal ulcer in the acute phase.
Use in Pregnancy and Lactation
During pregnancy and breastfeeding, it is possible to use according to indications in cases where the intended benefit to the mother outweighs the potential risk to the fetus or infant.
Pediatric Use
It is possible to use in children according to indications, in age-appropriate recommended doses and dosage forms. It is necessary to strictly follow the instructions for Plantago major preparations regarding indications and contraindications for use in children of different ages for specific dosage forms of Plantago major.
Special Precautions
The therapeutic effects of Plantago major are most fully manifested when using the juice.
The prepared infusion is stored in a cool place for no more than 2 days.
Drug Interactions
When treating respiratory diseases, it should not be used simultaneously with antitussive medications, as this makes it difficult to expel liquefied sputum.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Granules for oral suspension 1 g: sachet 25 pcs.
Marketing Authorization Holder
Vifitech, CJSC (Russia)
Dosage Form
| Plantaglucid | Granules for oral suspension 1 g: sachet 25 pcs. |
Dosage Form, Packaging, and Composition
| Granules for the preparation of an oral suspension | 1 sachet |
| Extract of Plantago major leaves | 1 g |
1 g – laminated paper sachets (25) – cardboard packs.
Granules for oral suspension 2 g: sachet 25 pcs.
Marketing Authorization Holder
Vifitech, CJSC (Russia)
Dosage Form
| Plantaglucid | Granules for oral suspension 2 g: sachet 25 pcs. |
Dosage Form, Packaging, and Composition
| Granules for the preparation of an oral suspension | 1 sachet |
| Extract of Plantago major leaves | 2 g |
1 g – laminated paper sachets (25) – cardboard packs.
Actovegin pills 200mg, 50pcs
Noopept, pills 10mg, 50pcs
Kagocel pills 12mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs
No-spa pills 40mg, 64pcs
Daivobet, ointment, 30g
Arbidol, capsules 100mg, 40pcs
Fenotropil pills 100mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Belosalic, ointment, 30g
Phenibut-Vertex pills 250mg, 20pcs
Nootropil pills 800mg, 30pcs
Picamilon pills 50mg, 60pcs 